Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initial Assessment of 18FDG-PET/MRI in Determining the Extent of Systemic Disease in Breast Cancer Patients.

NCT01672021 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01672021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01672021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initial Assessment of 18FDG-PET/MRI in Determining the Extent of Systemic Disease in Breast Cancer Patients.
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2012
Completion date
October 5, 2021
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer